Ex vivo expansion of hematopoietic stem and progenitor cells: Recent advances

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

567

WORD

393

HTML

4610

Tables (1-2)

494

Sum=6064

May 6, 2014 (publication date) through Jan 21, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hematol. May 6, 2014; 3(2): 18-28
Published online May 6, 2014. doi: 10.5315/wjh.v3.i2.18

Table 1 Comparison of the sources for hematopoietic stem cells

	Advantages	Disadvantages
Bone marrow	1 The longest history as a source of HSC	1 High stringency for HLA matching
	2 Well established procedure	2 Some complications associated with harvesting
		3 Risk of GVHD
Umbilical cord blood	1 Off-the-shelf availability	1 Delayed engraftment
	2 Reduced stringency for HLA matching	2 Lower yield
	3 Low risk of infection/transmission	3 Lack of additional immune cells
	4 Absence of donor risk
Peripheral blood	Compared to BM,	1 Extremely low level of HSC (1/100000) without “mobilization”
	1 More comfortable for donors	2 Risk of GVHD
	2 Better yield with mobilization

HSC: Hematopoietic stem cell; HLA: Human leukocyte antigen; BM: Bone marrow; GVHD: Graft-versus-host disease.

Citation: Kita K, Xiu F, Jeschke MG. Ex vivo expansion of hematopoietic stem and progenitor cells: Recent advances. World J Hematol 2014; 3(2): 18-28
URL: https://www.wjgnet.com/2218-6204/full/v3/i2/18.htm
DOI: https://dx.doi.org/10.5315/wjh.v3.i2.18